Воспалительные биомаркеры для стратификации сердечно-сосудистого риска
Background. Inflammatory processes play a key role in the pathogenesis of atherosclerosis and cardiovascular diseases (CVD). In recent years, considerable attention has been paid to inflammatory indices derived from routine complete blood counts for cardiovascular risk prediction. Aim. To provide a comprehensive analysis of current scientific evidence on inflammatory markers and their practical significance in predicting cardiovascular events. Materials and methods. A literature review was performed using publications from 2012–2025 retrieved from Scopus, Web of Science, PubMed, and Google Scholar. Systematic reviews, meta-analyses, large epidemiological studies, and controlled clinical trials reporting quantitative prognostic measures (HR, OR, RR, AUC) were included. Results. Multiple inflammatory indicators show independent prognostic value for cardiovascular complications. The most extensively studied are the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI). Thresholds and prognostic accuracy estimates reported in the literature were obtained in heterogeneous clinical populations and for different outcomes; therefore, direct comparison is inappropriate. Conclusion. Inflammatory indices are accessible, cost-effective, and reproducible biomarkers that may complement traditional risk factors in cardiovascular risk stratification. Their integration into clinical practice may improve risk assessment, but prospective validation of threshold values is required.
Сведения
- Журнал
- CARDIOLOGY OF UZBEKISTAN
- Опубликовано
- 2026 · Т. 3, № 2, С. 85-96
- Язык
- Русский
- ISSN
- 3060-4850
- Издатель
- Republican Specialized Scientific-Practical Medical Center of Cardiology
- Аффилиации
- Республиканский специализированный научно-практический медицинский центр кардиологии филиал г. Джиззак